Detalhe da pesquisa
1.
A Fc engineering approach to define functional humoral correlates of immunity against Ebola virus.
Immunity
; 54(4): 815-828.e5, 2021 04 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33852832
2.
Ebola Virus Epidemiology, Transmission, and Evolution during Seven Months in Sierra Leone.
Cell
; 161(7): 1516-26, 2015 Jun 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-26091036
3.
Clinical Sequencing Uncovers Origins and Evolution of Lassa Virus.
Cell
; 162(4): 738-50, 2015 Aug 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-26276630
4.
Virus genomes reveal factors that spread and sustained the Ebola epidemic.
Nature
; 544(7650): 309-315, 2017 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-28405027
5.
High crossreactivity of human T cell responses between Lassa virus lineages.
PLoS Pathog
; 16(3): e1008352, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32142546
6.
Identification of Common CD8+ T Cell Epitopes from Lassa Fever Survivors in Nigeria and Sierra Leone.
J Virol
; 94(12)2020 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32269122
7.
Analysis of CD8+ T cell response during the 2013-2016 Ebola epidemic in West Africa.
Proc Natl Acad Sci U S A
; 115(32): E7578-E7586, 2018 08 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30038008
8.
Survivors of Ebola Virus Disease Develop Polyfunctional Antibody Responses.
J Infect Dis
; 221(1): 156-161, 2020 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31301137
9.
Ebola-Specific CD8+ and CD4+ T-Cell Responses in Sierra Leonean Ebola Virus Survivors With or Without Post-Ebola Sequelae.
J Infect Dis
; 222(9): 1488-1497, 2020 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32436943
10.
Endotheliopathy and Platelet Dysfunction as Hallmarks of Fatal Lassa Fever.
Emerg Infect Dis
; 26(11): 2625-2637, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33079033
11.
Clinical illness and outcomes in patients with Ebola in Sierra Leone.
N Engl J Med
; 371(22): 2092-100, 2014 Nov 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-25353969
12.
Field Validation of the ReEBOV Antigen Rapid Test for Point-of-Care Diagnosis of Ebola Virus Infection.
J Infect Dis
; 214(suppl 3): S203-S209, 2016 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27521365
13.
Analytical Validation of the ReEBOV Antigen Rapid Test for Point-of-Care Diagnosis of Ebola Virus Infection.
J Infect Dis
; 214(suppl 3): S210-S217, 2016 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27587634
14.
An Outbreak of Ebola Virus Disease in the Lassa Fever Zone.
J Infect Dis
; 214(suppl 3): S110-S121, 2016 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27402779
15.
Clinical validation trial of a diagnostic for Ebola Zaire antigen detection: Design rationale and challenges to implementation.
Clin Trials
; 13(1): 66-72, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26768566
16.
Development of Prototype Filovirus Recombinant Antigen Immunoassays.
J Infect Dis
; 212 Suppl 2: S359-67, 2015 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26232440
17.
Ebola Virus Diagnostics: The US Centers for Disease Control and Prevention Laboratory in Sierra Leone, August 2014 to March 2015.
J Infect Dis
; 212 Suppl 2: S350-8, 2015 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26232439
18.
Undiagnosed acute viral febrile illnesses, Sierra Leone.
Emerg Infect Dis
; 20(7): 1176-82, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24959946
19.
Genome-wide association study identifies human genetic variants associated with fatal outcome from Lassa fever.
Nat Microbiol
; 9(3): 751-762, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38326571
20.
A prospective, multi-site, cohort study to estimate incidence of infection and disease due to Lassa fever virus in West African countries (the Enable Lassa research programme)-Study protocol.
PLoS One
; 18(3): e0283643, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36996258